US Stem Cell Inc (USRM)

[Dragon Lady]

That's a PR written and put out by the company. It's not like MSN money or some actual analyst coverage wrote it or some financial news/reporter actually "covered" the company or anything. They "scrape" that content now days off of "marketwired" and similar paid-PR outlets/PR firms where Bioheart pays to post that PR.

http://www.marketwired.com/

http://www.marketwired.com/AdvancedSearch/AdvancedSearchResults.aspx?sid=24f3b065-0bf5-4ec6-ba52-5a6d1b95163b

It's from "marketwired" and put out by the BHRT "PR" people. They wrote it. No surprises there IMO. Figured "PR" was due about something.

IMO, it kinda left out the little "tid bits" like massive dilution, still having large losses from operations, almost no cash left at end of qtr (about $90K which doesn't even pay the salary increases + bonuses Tomas and Comella just got- see 10-Q filing), continued use of toxic convertible debt for very small increments of cash to survive (see latest 10-Q ASHER, Daniel James and 4th Man "financing") little "stuff" like that. Oh, and that nothing on their two key, phase II/III trials happened as usual, same as for last approx. 5 yrs- that Marvel and Regen are in the parking spot, unmoved. Somehow those glowing PR's just always leave out that "stuff", don't know why? 51 million shares of dilution in a single qtr, almost 600 million fully diluted shares now, pretty much doubling in about a one yr period and only $15K went to R&D for the whole qtr, but there was still almost no cash left at end of qtr?

Oh well, just another PR "story" IMO.